Found 113 matching trials
Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma PHASE2 The purpose of this study is to evaluate the efficacy of ibrutinib (PCI-327...
Show More Location
UCLA Medical Center
Learn More & Join Trial
Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia PHASE1 This is a two-part, non-randomized, open-label Phase I clinical study. The ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma PHASE1 The purpose of this Phase 1/2 study is to evaluate the safety and efficacy ...
Show More Location
University of California Irvine Health Chao Family Comprehensive Cancer Center
Learn More & Join Trial
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection PHASE1 This phase I trial studies the side effects and best dose of ibrutinib in t...
Show More Location
UCLA Center for Clinical AIDS Research and Education
Learn More & Join Trial
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19) PHASE2 This phase II trial studies the effects of ibrutinib in treating patients w...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults PHASE1 The purpose of this study is to assess the relative bioavailability (the ex...
Show More Location
Multiple Locations
Learn More & Join Trial
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) PHASE2 This is a Phase 2, multicenter, open-label study to provide continued suppl...
Show More Status
Active Not Recruiting
Location
Uab Comprehensive Cancer Center
Learn More & Join Trial
A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia PHASE1 This research study is evaluating a combination of two drugs, ibrutinib and...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma PHASE2 First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Show More Location
University Hospital of Mainz
Learn More & Join Trial
Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) PHASE1 The purpose of this study is to test any good or bad effects of the study d...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial